Inside the $2.3 Billion Problem: How Biotech Startups Are Rethinking Supply Chains
With the average cost of bringing a new drug to market now exceeding two billion dollars, early-stage biotech companies are turning to marketplace procurement platforms to cut overhead and redirect resources where they matter most — the lab bench.